Golden
BioMedPartners

BioMedPartners

A European private equity and venture capital firm that provides financing to early- and mid-stage healthcare and human life science companies

BioMedPartners is a European private equity and venture capital firm that provides financing to early- and mid-stage healthcare and human life science companies. Founded 2017 in Basel, Basel-Stadt, Switzerland by Gerhard Ries, the company invests in early and late stage ventures. It usually funds grants, Series A, Series B, Series D, and other venture rounds. Its portfolio companies include Aleva Neurotherapeutics, ImmunOs Therapeutics, Inotrem, Curetis, and Alentis Therapeutics. As of January 2020, the company had 19 exits and 68 investments. The company focuses on pharmaceuticals, biotechnology, diagnostics and medical technology. 





Timeline

2017

Founded

People

Name
Role
LinkedIn

Andreas Wallnöfer

General Partner



Karl Deres

Venture Partner



Patrick Burgermeister

Partner



Stefan Fäs

Chief Financial Officer & Partner



Thomas Möller

General Partner



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services

ImmunOs Therapeutics







Alentis Therapeutics







Aleva Neurotherapeutics







Amal Therapeutics







Amal Therapeutics







Camel-IDS







Hookipa Pharma







Miracor Medical







TOLREMO therapeutics







Tricares







References